Alimera Sciences (ALIM) director Kaseta received 50,000 Stock Option (Right to Buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Michael Kaseta (director at Alimera Sciences Inc., ALIM) reported that they received 50,000 Stock Option (Right to Buy) on Oct 2, 2023.
- Reporting person
- Kaseta Michael
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Oct 2, 2023 | Grant or award (A) | Stock Option (Right to Buy)On 50,000 Common Stock1 | +50,000 | - | - | 50,000 direct |
Holdings before and after
- Stock Option (Right to Buy): 0 to 50,000 direct
Footnotes from the filing
- 1. The option vests and becomes exercisable in equal monthly installments beginning on August 1, 2023. Vests in full on the earlier of August 1, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, provided the Reporting Person provides continuous service to the Issuer through such date, with the final installment adjusted as necessary to avoid any fractional shares in any installment.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Kaseta report in this ALIM Form 4?
Michael Kaseta (director at Alimera Sciences Inc., ALIM) reported that they received 50,000 Stock Option (Right to Buy) on Oct 2, 2023.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for ALIM
Earlier insider filings at ALIM
- Oct 4, 2023Eiswirth Richard S Jr was granted 400,000 shares, increasing direct ownership by 124% to 722,518 units (SEC Form 4)
- Sep 15, 2023SEC Form 4: Caligan Partners Lp sold $1,962,810 worth of shares (579,000 units at $3.39) and bought $1,962,810 worth of shares (579,000 units at $3.39)
- Aug 18, 2023SEC Form 4: Morgan Adam converted options into 11,948,879 shares
- Aug 17, 2023SEC Form 4: Caligan Partners Lp converted options into 16,356,377 shares
- May 19, 2023SEC Form 4 filed by Morgan Adam
Quantisnow market dataNASDAQ
ALIM
Alimera Sciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2010
Get push alerts for ALIM
Full ALIM profile on Quantisnow Follow ALIM and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time